178 related articles for article (PubMed ID: 9763407)
1. Absorption, distribution, metabolism, and excretion of atevirdine in the rat.
Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Schuette MR; Judy RW; Voorman RL; Maio SM; Slatter JG
Drug Metab Dispos; 1998 Oct; 26(10):1008-18. PubMed ID: 9763407
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats.
Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Fagerness PE
Drug Metab Dispos; 1997 Feb; 25(2):228-42. PubMed ID: 9029054
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Hauer MJ; Zhang W; Branstetter DG
Drug Metab Dispos; 1997 Jul; 25(7):828-39. PubMed ID: 9224777
[TBL] [Abstract][Full Text] [Related]
4. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys.
Chang M; Sood VK; Kloosterman DA; Hauer MJ; Fagerness PE; Sanders PE; Vrbanac JJ
Drug Metab Dispos; 1997 Jul; 25(7):814-27. PubMed ID: 9224776
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat.
Matsui K; Mishima M; Nagai Y; Yuzuriha T; Yoshimura T
Drug Metab Dispos; 1999 Dec; 27(12):1406-14. PubMed ID: 10570021
[TBL] [Abstract][Full Text] [Related]
8. Disposition of [1'-(14)C]stavudine after oral administration to humans.
Zhou L; Kaul S; Liu-Kreyche P; Tran SB; Espina RR; Warrack BM; Roongta VA; Iyer RA
Drug Metab Dispos; 2010 Apr; 38(4):655-66. PubMed ID: 20053818
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
10. Metabolic disposition of casopitant, a potent neurokinin-1 receptor antagonist, in mice, rats, and dogs.
Miraglia L; Pagliarusco S; Bordini E; Martinucci S; Pellegatti M
Drug Metab Dispos; 2010 Oct; 38(10):1876-91. PubMed ID: 20622044
[TBL] [Abstract][Full Text] [Related]
11. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat.
Mountfield RJ; Kiehr B; John BA
Drug Metab Dispos; 2000 May; 28(5):503-13. PubMed ID: 10772628
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Prakash C; Cui D; Potchoiba MJ; Butler T
Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients.
Been-Tiktak AM; Vrehen HM; Schneider MM; van der Feltz M; Branger T; Ward P; Cox SR; Harry JD; Borleffs JC
Antimicrob Agents Chemother; 1995 Mar; 39(3):602-7. PubMed ID: 7793859
[TBL] [Abstract][Full Text] [Related]
16. The absorption, distribution, metabolism and elimination of bevirimat in rats.
Bullock P; Larsen D; Press R; Wehrman T; Martin DE
Biopharm Drug Dispos; 2008 Oct; 29(7):396-405. PubMed ID: 18615840
[TBL] [Abstract][Full Text] [Related]
17. Metabolism studies of the anti-tumor agent maytansine and its analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry.
Liu Z; Floss HG; Cassady JM; Chan KK
J Mass Spectrom; 2005 Mar; 40(3):389-99. PubMed ID: 15674857
[TBL] [Abstract][Full Text] [Related]
18. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
Balani SK; Kauffman LR; Arison BH; Olah TV; Goldman ME; Varga SL; O'Brien JA; Ramjit HG; Rooney CS; Hoffman JM
Drug Metab Dispos; 1994; 22(2):200-5. PubMed ID: 7516852
[TBL] [Abstract][Full Text] [Related]
20. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
